Vivek Kalagara
CEO
Market trends suggest that using artificial intelligence to improve drug discovery, optimize patient care, and automate healthcare processes will become more widespread. Moreover, this new trend represents an oppor -tunity for integrating blockchain into secure data management in addition to nanotechnology in advanced treatments, which is expected to make healthcare affordable, efficient, and personalized all over the world.
Nevertheless, there are challenges that consumers face, such as handling large volumes of unstructured data, meeting regulatory requirements, and integrating sophisticated technologies like AI. Datafoundry, founded in 2016, specializes in AI-driven solutions for the Life Sciences and Healthcare sectors.
With proprietary AI algorithms, the firm simplifies data-driven operations, helping organizations build data fabrics for seamless integration, and its expert team delivers scalable, efficient and secure data science solutions, driving innovation and excellence.
Datafoundry was born from a deep-seated desire to give back to society, combined with a vision to harness the power of technology
to solve critical problems in the life sciences and healthcare sectors. After a 20 year career in the US, working at the intersection of technology and life sciences, the founder relocated to India in 2016 to build a technology-driven company.
With a focus on AI, the firm quickly established itself as a leader in data science, AI/ML, and deep domain expertise. Datafoundry's journey from startup to scaleup has been marked by strategic decisions and resilience. Early success in product engineering and data science services led to a pivot towards developing AI models and business applications. "Despite industry hesitance, we are focused on long-term vision, building a world-class team and proprietary AI products instead of chasing short-term gains," speaks Vivek Kalagara, CEO.
Revolutionizing Healthcare through AI & Data
Datafoundry's flagship product, the DF Safety AI Platform, enhances drug safety by predicting adverse drug reactions, automating safety case intake and assessment, and managing risk through AI-powered insights. The DF Digitalize AI Platform also leverages proprietary AI/ML models to convert unstructured, multi-modal data into structured data, facilitating rapid prototyping and deployment of use cases. This platform is particularly effective in processing clinical trial protocols, drug labeling documents, and electronic health records.
(EHRs), making it invaluable for pharma companies, clinical research organizations, and healthcare providers. Beyond these platforms, the firm offers AI and data science services to clients across various industries, including computer vision, natural language processing, and statistical analysis. These solutions help organizations optimize processes, generate actionable insights, and ultimately improve patient outcomes.
Data foundry implements re-responsible AI by building algorithms on high-quality curated datasets, investing significantly in data standardization through innovative automation. While AI aids decision-making, especially in critical areas like patient safety and health outcomes, Datafoundry emphasizes the necessity of a human-in-the-loop approach.
The company also ensures the secure deployment of ML pipelines to protect privacy and data integrity while actively addressing bias and model drift throughout the algorithm's lifecycle. The firm has garnered impressive feedback from clients across key markets, including Pharma, Cosmetics, and Medical Devices. The company's AI-powered Safety Platform has attracted significant interest, with early adopters highlighting its effectiveness in reducing costs and improving compliance.
Data foundry's roadmap includes expanding its AI solutions across life sciences and healthcare, leveraging data to address core industry challenges. While revenue targets are important, the firm prioritizes creating impactful solutions and generating positive outcomes. The company is set to grow its influence, with the potential to extend its innovations to new areas and markets.
With a focus on AI, the firm quickly established itself as a leader in data science, AI/ML, and deep domain expertise. Datafoundry's journey from startup to scaleup has been marked by strategic decisions and resilience. Early success in product engineering and data science services led to a pivot towards developing AI models and business applications. "Despite industry hesitance, we are focused on long-term vision, building a world-class team and proprietary AI products instead of chasing short-term gains," speaks Vivek Kalagara, CEO.
Revolutionizing Healthcare through AI & Data
Datafoundry's flagship product, the DF Safety AI Platform, enhances drug safety by predicting adverse drug reactions, automating safety case intake and assessment, and managing risk through AI-powered insights. The DF Digitalize AI Platform also leverages proprietary AI/ML models to convert unstructured, multi-modal data into structured data, facilitating rapid prototyping and deployment of use cases. This platform is particularly effective in processing clinical trial protocols, drug labeling documents, and electronic health records.
(EHRs), making it invaluable for pharma companies, clinical research organizations, and healthcare providers. Beyond these platforms, the firm offers AI and data science services to clients across various industries, including computer vision, natural language processing, and statistical analysis. These solutions help organizations optimize processes, generate actionable insights, and ultimately improve patient outcomes.
Data foundry implements re-responsible AI by building algorithms on high-quality curated datasets, investing significantly in data standardization through innovative automation. While AI aids decision-making, especially in critical areas like patient safety and health outcomes, Datafoundry emphasizes the necessity of a human-in-the-loop approach.
The company also ensures the secure deployment of ML pipelines to protect privacy and data integrity while actively addressing bias and model drift throughout the algorithm's lifecycle. The firm has garnered impressive feedback from clients across key markets, including Pharma, Cosmetics, and Medical Devices. The company's AI-powered Safety Platform has attracted significant interest, with early adopters highlighting its effectiveness in reducing costs and improving compliance.
Data foundry's roadmap includes expanding its AI solutions across life sciences and healthcare, leveraging data to address core industry challenges. While revenue targets are important, the firm prioritizes creating impactful solutions and generating positive outcomes. The company is set to grow its influence, with the potential to extend its innovations to new areas and markets.
